These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29699206)

  • 1. Cardiovascular consequences of hormone therapy in postmenopausal women: Messages to clinicians.
    Ylikorkala O; Mikkola T
    Reprod Med Biol; 2005 Mar; 4(1):1-6. PubMed ID: 29699206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
    Clarkson TB; Meléndez GC; Appt SE
    Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy.
    Bhavnani BR; Strickler RC
    J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in menopause.
    Marko KI; Simon JA
    Menopause; 2018 Feb; 25(2):217-230. PubMed ID: 28953214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
    Bassuk SS; Manson JE
    Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Timing Hypothesis: Hormone Therapy for Treating Symptomatic Women During Menopause and Its Relationship to Cardiovascular Disease.
    Mehta JM; Chester RC; Kling JM
    J Womens Health (Larchmt); 2019 May; 28(5):705-711. PubMed ID: 30484736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart.
    Hodis HN
    Cleve Clin J Med; 2008 May; 75 Suppl 4():S3-12. PubMed ID: 18697261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
    Bassuk SS; Manson JE
    Metabolism; 2016 May; 65(5):794-803. PubMed ID: 27085786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
    Langer RD
    Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
    Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
    Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
    Bhupathiraju SN; Grodstein F; Rosner BA; Stampfer MJ; Hu FB; Willett WC; Manson JE
    Am J Epidemiol; 2017 Sep; 186(6):696-708. PubMed ID: 28938710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.
    Tuomikoski P; Mikkola TS
    Ann Med; 2014 Feb; 46(1):1-7. PubMed ID: 24266727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.